Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹156 Cr
verified against source
Revenue YoY
-31%
reported change
EBITDA
₹100 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Best Agrolife reported a weak FY26 with consolidated revenue of ₹1,257 crore, down 31% YoY, and PAT of just ₹9 crore (vs ₹70 crore in FY25). The Q4 quarter was particularly weak, with revenue of ₹156 crore (down 43% YoY) and an EBITDA loss of ₹27 crore. The decline was driven by adverse weather, elevated channel inventory, and a conscious decision to defer ~₹50-70 crore of sales in March to protect margins amid rising raw material costs. Management highlighted that patented products now contribute 40% of branded sales (up from 30%), and inventory has been reduced from ₹958 crore in FY24 to ₹651 crore. For FY27, they expect gradual recovery supported by two rounds of price increases, new patented product launches, and a shift toward B2B technical sales. Key risks include El Niño impact on the rabi season and continued raw material volatility from the Gulf conflict.
Colored figures show movement against the previous available record.
Guidance to track
- Management implemented price hikes in April and May 2026 to offset rising input costs, expected to support profitability from Q1 FY27.
- The company plans to launch three new patented products (fluan, bitcoin cubit power extra, and the shampoo) in FY27 to strengthen the specialized crop protection portfolio.
- Management aims to reduce sales returns to less than 20% in FY27, down from the current 20-21%.
- New capex at existing plants has been postponed; no major capital expenditure planned in the near term.
Risks flagged
- El Niño is expected to kick in between September and October, potentially causing a 2°C+ temperature rise and impacting rabi crops.
- The ongoing Gulf conflict has increased prices of solvents and formulations, creating margin pressure.
- An analyst raised concerns about receivables of ~₹500 crore (50% of sales) and potential write-offs; management defended by citing seasonal collection patterns.
- An analyst noted that the company has missed guidance multiple times, including Q4 FY26 where losses doubled despite earlier expectations of a small loss or profit.
Key quotes
- We consciously calibrated this using Mars B2B segment. While this current decision impacted near-term revenue by approximately 50 to 70 crores, we believe it was necessary to protect medium-term profitability and maintain channel discipline.
- Patent products now contribute up to 40% of our total branded sales which till last year was about 30%.
- We are in a full-fledged production times. So our capital requirement is higher. So even at this present time if you see our utilization of the bank facilities it is at around 85 90%.
Research modules